Loading…
Loading…
TFX · NYSE · Healthcare
“A medical device company trading at negative earnings with a $4.8B valuation offers no margin of safety for the prudent value investor.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$4.76B
P/E Ratio
-5.26
Forward P/E
—
EPS
$-20.30
PEG Ratio
-0.01
Book Value
$70.03
Dividend Yield
1.25%
Profit Margin
-45.45%
ROE
-28.98%
Use the interactive ipo calendar with pre-loaded data for Teleflex Incorporated. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for TFX: